# DEDICA (Dose of HEparin During Coronary Angioplasty) Trial

Study · id `cardio:ct-nct01694459` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01694459](<https://clinicaltrials.gov/study/NCT01694459>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01694459

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1000 participants.

## Technical summary

Registry record NCT01694459. Randomized; single masking; primary purpose treatment. Start 2010-01 (registry gives no type); primary completion 2012-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 1000 participants (planned count; ClinicalTrials.gov record NCT01694459, source copy `cardio:ctgov-nct01694459-2012-09-27`, retrieved 2026-10-26)
- Start date: 2010-01 (registry gives no type) (ClinicalTrials.gov record NCT01694459, source copy `cardio:ctgov-nct01694459-2012-09-27`, retrieved 2026-10-26)
- Primary completion: 2012-12 (anticipated) (ClinicalTrials.gov record NCT01694459, source copy `cardio:ctgov-nct01694459-2012-09-27`, retrieved 2026-10-26)
- Completion: 2012-12 (anticipated) (ClinicalTrials.gov record NCT01694459, source copy `cardio:ctgov-nct01694459-2012-09-27`, retrieved 2026-10-26)
- Countries: Italy (ClinicalTrials.gov record NCT01694459, source copy `cardio:ctgov-nct01694459-2012-09-27`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01694459-2012-09-27`, retrieved 2026-10-26)

## The registry's words

- Brief title: DEDICA (Dose of HEparin During Coronary Angioplasty) Trial
- Acronym: DEDICA
- Condition: Stable Angina
- Condition: Angina, Unstable
- Condition: Non-ST Elevation (NSTEMI) Myocardial Infarction
- Intervention (Drug): Low-dose heparin
- Intervention (Drug): Standard dose heparin
- Lead sponsor: San Filippo Neri General Hospital
- Lead sponsor class: OTHER
- Collaborator: University of Roma La Sapienza
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: Non-ST-elevation heart attack (NSTEMI) (`cardio:nstemi`)
- Registry condition terms include this condition: Stable angina (`cardio:stable-angina`)
- Registry condition terms include this condition: Unstable angina (`cardio:unstable-angina`)
- Registry intervention name matches this record once doses, forms and salt words are removed: Heparin (`cardio:heparin`)
- Registry intervention is a member of this class by a sourced record link: Heparins and low-molecular-weight heparins (`cardio:heparins-and-low-molecular-weight-heparins`)
- Registry intervention is a member of this class by a sourced record link: Anticoagulants (`cardio:anticoagulants`)
- Registry lists this organization as a collaborator: University of Roma La Sapienza (`cardio:org-university-of-roma-la-sapienza`)

## Provenance

Content hash: 7c52f0b6bbef32ff1d8e6c86ba0eb4a717fe17cfcbe47f0918b42c0e37e602d8
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
